Scientists seek crystal ball for pancreatic cancer survival
NCT ID NCT07373691
Summary
This study aims to build a better prediction tool for patients with advanced pancreatic cancer. Researchers will look at patient scans, tissue samples, and genetic information to create models that forecast how long patients might live and how well they might respond to their first chemotherapy treatment. The goal is to gather knowledge that could help doctors make more personalized treatment plans in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, China
Conditions
Explore the condition pages connected to this study.